Objective: This study aimed to verify the prognostic impact of pleural invasion according to the revised TNM classification, seventh edition. Methods: The study consisted of 1488 patients with surgically resected non-small cell carcinoma. The degree (pl0 -3) and location of pleural invasion were examined using hematoxylin and eosin-and elastica van Gieson-stained slides, and outcome was compared with stratification by several clinicopathological factors.
INTRODUCTION
The TNM classification of malignant tumours was revised, and the seventh edition was published in 2009 (1) . Pathological pleural invasion was classified as follows: pl0, no invasion to the visceral pleura; pl1, invasion beyond the elastic fibres; pl2, invasion to the pleural surface; and pl3, invasion to the parietal pleura. pl1-2 corresponds to pT2a, and pl3 corresponds to pT3. In the present study, interlobar pleural invasion was classified as pl3 that corresponds to pT2, according to the General Rule for Clinical and Pathological Record of Lung Cancer, seventh edition, published in 2010 by the Japanese Lung Cancer Society (2) .
Several previous studies reported that patients with pleural invasion had inferior outcomes when compared with those without pleural invasion (3 -8) . Osaki et al. (6) 
and Shimizu
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However, previous TNM classifications did not include detailed pathological criteria for pleura invasion. In the General Rule for Clinical and Pathological Record of Lung Cancer, sixth edition, published in 2003 by the Japanese Lung Cancer Society (9), pl2 was classified as pleural invasion, and pl1 was not classified as pleural invasion. Worldwide, both pl1 and pl2 were customarily classified as pleural invasion. In the seventh edition of the TNM classification (1), pl1 and pl2 were classified as pleural invasion.
In the TNM classification, mediastinal pl3 was classified as pT4 in the sixth edition (10), but it was classified as pT3 in the seventh edition (1). Interlobar pl3 was classified as pT2, and diaphragmatic pl3 and lateral (chest wall) pl3 were classified as pT3 in both the sixth and seventh editions.
However, pleural invasion has been diagnosed using elastica van Gieson-stained slides only in a small number of institutions. Travis et al. reviewed six reports that evaluated pleural invasion using elastica van Gieson-stained slides (3 -8) , after which they recommended using elastica-stained slides to accurately diagnose pleural invasion (11) .
In the present study, pleural invasion was evaluated using elastica van Gieson-stained slides in 1488 patients with surgically resected non-small cell lung carcinoma to verify that both pl1 and pl2 should be classified as pleural invasion (pT2a) in the point of outcome. In addition, the influence of tumour size, lymph node status, histology and location of pleural invasion on patient outcome was also evaluated.
MATERIALS AND METHODS

PATIENT SELECTION
The present study consisted of 1488 consecutive patients with non-small cell lung carcinoma who underwent lobectomy or pneumonectomy at the National Cancer Center Hospital, Tokyo, Japan between June 1997 and May 2004. Patients with tumours with positive surgical margins were excluded. TNM stages were determined according to the Union Internationale Contre le Cancer (International Union Against Cancer) staging system, seventh edition, published in 2009 (1) . Clinical information was obtained from the medical records. The median follow-up time was 66 months (range, 0 -142 months). Informed consent was obtained from each patient. The study was approved by the institutional review board of the National Cancer Center.
HISTOPATHOLOGY
The materials were fixed in 10% formalin overnight. The lobectomy/pneumonectomy specimens were cut at 5 -10 mm intervals. At our institution, blocks from whole sections, including the maximum diameter of the primary tumour as well as the hilar and peripheral lung distance from the primary tumour, were made routinely with several additional tumour sections. An average of 15 blocks per patient, including the primary tumour (2 -10 blocks) and the background lung tissue (5 -10 blocks) were prepared using routine procedures, excluding separately processed lymph nodes. Hematoxylin and eosin-and elastica van Gieson-stained tumour slides were prepared for routine examination to assess the degree of pleural invasion and vessel invasion. According to the TNM classification, seventh edition (1), pathological pleural invasion was classified as follows: pl0, no invasion to the visceral pleura; pl1, invasion beyond the elastic fibre; pl2, invasion to the pleural surface; and pl3, invasion to the parietal pleura. In the present study, interlobar pleural invasion was classified as pl3, according to the General Rule for Clinical and Pathological Record of Lung Cancer, seventh edition, published in 2010 by the Japanese Lung Cancer Society (2). If both visceral and parietal pleura adhere, and internal and external visceral pleural and parietal pleural elastic fibres highlighted using elastic staining were destroyed by tumour, we judged as pl3. The prognostic significance of pleural invasion was also evaluated by stratification according to tumour size, lymph node status and histology. The location of pl3 tumours was classified as diaphragmatic, interlobar, lateral and mediastinal. The histological subtype of non-small cell carcinoma was classified according to the World Health Organization Classification of Tumours, Pathology and Genetics, Tumours of the Lung, Pleura, Thymus and Heart, published in 2004 (12) .
STATISTICAL ANALYSIS
Overall survival (OS) curves were drawn using the KaplanMeier method. Differences in survival curves were compared using the log-rank test. Univariate and multivariate analyses were performed using the Cox's proportional hazard model for clinicopathological parameters. Differences were considered significant at P , 0.05.
RESULTS
PATIENT CHARACTERISTICS
Clinical information and histopathological results are summarized in Table 1 . The patient group consisted of 893 men and 595 women ranging in age from 27 to 85 years with a median age of 65 years. The histology was adenocarcinoma in 1074 patients (72%), squamous cell carcinoma in 300 patients (20%) and other (large cell neuroendocrine carcinoma, 47; pleomorphic carcinoma, 31; adenosquamous carcinoma, 18; large cell carcinoma, 18) in 114 patients (8%). The 5-year OS rate of the 1488 patients was 72%. According to Cox's univariate analysis, age, gender, smoking status, tumour size, lymph node status, pathological stage, histology of the tumour and pleural invasion were significantly (all P , 0.0001) correlated with the risk of death from cancer spread. According to Cox's multivariate analysis, seven parameters (age, gender, smoking status, tumour size, lymph node status, histology of the tumour and pleural invasion) were independent risk factors for OS (Table 2) .
PROGNOSTIC SIGNIFICANCE OF THE DEGREE OF PLEURAL INVASION STRATIFIED BY TUMOUR SIZE, HISTOLOGY AND LYMPH NODE STATUS
The 5-year OS rates of 1006, 261, 86 and 135 patients with pl0, pl1, pl2 and pl3 tumours were 80, 60, 55 and 52%, respectively. OS curves differed significantly between the patients with pl0 tumours and those with pl1 tumours (P , 0.0001) (Fig. 1) . However, the OS among patients with pl1, pl2 or pl3 tumours was not significantly different.
We examined the prognostic significance of pleural invasion in patient groups stratified by age, gender, smoking status, tumour size, histology and lymph node status. Concerning the outcome of patients stratified by tumour size, the 5-year OS rates of 62, 462, 418, 368, 128 and 50 patients with 1 cm, 1 , 2 cm, 2 , 3 cm, 3 , 5 cm, 5 , 7 cm and .7 cm tumours were 92, 84, 77, 62, 42 and 44%, respectively. OS curves differed significantly between patients with 1 , 2 cm tumours and those with 2 , 3 cm tumours (P ¼ 0.001), between patients with 2 , 3 cm tumours and those with 3 , 5 cm tumours (P , 0.0001) and between those with 3 , 5 cm tumours and those with 5 , 7 cm tumours (P , 0.0001); however, no significant differences were observed between patients with 1 cm tumours and those with 1 , 2 cm tumours and between those with 5 , 7 cm tumours and those with .7 cm tumours. Concerning the outcome of patients with different pleural invasion tumour stratified by tumour size, the 5-year OS rates between the 542 Pleural invasion of lung carcinoma patients with pl0 and pl1 tumours significantly differed among patients with 1 , 2 cm (P ¼ 0.004, Fig. 2A ), 2 , 3 cm (P ¼ 0.003, Fig. 2B ) and 3 , 5 cm tumours (P ¼ 0.02, Fig. 2C) ; however, no significant differences were observed among patients with 1 cm, 5 , 7 cm and ,7 cm tumours. OS curves were not significantly different among patients with pl1, pl2 and pl3 tumours irrespective of tumour size. Of the 1074 patients with adenocarcinoma, the 5-year OS rates of 795, 160, 68 and 51 patients with pl0, pl1, pl2 and pl3 tumours were 85, 62, 60 and 61%, respectively. OS rates differed significantly between patients with pl0 adenocarcinoma and those with pl1 adenocarcinoma (P , 0.0001) (Fig. 3A) . OS curves did not differ significantly among patients with pl1, pl2 and pl3 adenocarcinoma. Of the 300 patients with squamous cell carcinoma, the 5-year OS rates of 157, 73, 11 and 59 patients with pl0, pl1, pl2 and pl3 tumours were 63, 56, 36 and 46%, respectively. OS curves differed marginally, but significantly between patients with pl0 squamous cell carcinoma and those with pl1 squamous cell carcinoma (P ¼ 0.043) (Fig. 3B) . OS curves did not differ significantly among patients with pl1, pl2 and pl3 squamous cell carcinoma. Of the 114 patients with other non-small cell carcinomas, the 5-year OS rates of 56, 27, 6 and 25 patients with pl0, pl1, pl2 and pl3 tumours were 55, 52, 33 and 48%, respectively. OS curves did not differ significantly among patients with pl0, pl1, pl2 and pl3 tumours.
Of the 1074 patients with no lymph node metastasis ( pN0), the 5-year OS rates of 818, 150, 38 and 68 patients with pl0, pl1, pl2 and pl3 tumours were 87, 73, 74 and 68%, respectively. OS rates differed significantly between patients with pl0 pN0 tumours and those with pl1 pN0 tumours (P , 0.0001) (Fig. 4A) . OS curves did not differ significantly among patients with pl1, pl2 and pl3 pN0 tumours. Of the 414 patients with lymph node metastasis (pNþ), the 5-year OS rates of 190, 110, 47 and 67 patients with pl0, pl1, pl2 and pl3 tumours were 50, 41, 40 and 36%, respectively. OS curves did not differ significantly among patients with pl0, pl1, pl2 and pl3 pNþ tumours (Fig. 4B) .
The OS curves of patients with different pleural invasion tumour stratified by age, gender and smoking status differed significantly between those with pl0 tumours and those with pl1 tumours (P , 0.0001) in all the patient subgroups (data not shown).
PROGNOSTIC SIGNIFICANCE OF PLEURAL INVASION (PL3) STRATIFIED BY LOCATION
Of 135 patients with pl3 tumours, 61 patients (45%) exhibited invasion to the lateral parietal pleura, 39 patients (29%) exhibited invasion to the mediastinal pleura, 20 patients (15%) exhibited invasion to the other lobes (interlobar pl3) and 15 patients (11%) exhibited invasion to the diaphragm.
Of 61 patients with lateral pl3, tumours deeply infiltrated into the soft tissues and ribs of the chest wall in 9 patients and tumours slightly infiltrated into the chest wall in the other 52 patients. The 5-year OS rates of patients with interlobar, lateral, mediastinal and diaphragmatic pl3 tumours were 65, 51, 51 and 40%, respectively. OS did not differ significantly among patients with interlobar, lateral, mediastinal and diaphragmatic pl3 tumours (Fig. 5) . However, patients with interlobar pl3 tumours tended to have better outcomes than those with other pl3 tumours, and patients with diaphragmatic pl3 tumours tended to have worse outcome than those with other pl3 tumours.
DISCUSSION
Following the publication of the TNM classification, seventh edition, pleural invasion was diagnosed using elastica van OS curves according to the degree of pleural invasion for 1074 patients with adenocarcinoma and 300 patients with squamous cell carcinoma. (A) Among 1074 patients with adenocarcinoma, the curve for 795 patients with pl0 tumours differed significantly from that for 160 patients with pl1 tumours (P , 0.0001). The curves for 160, 68 and 51 patients with pl1, pl2 and pl3 tumours, respectively, did not differ significantly. (B) Among 300 patients with squamous cell carcinoma, the curve for 157 patients with pl0 tumours differed significantly from that for 73 patients with pl1 tumours (P ¼ 0.043). The curves for 73, 11 and 59 patients with pl1, pl2 and pl3 tumours, respectively, did not differ significantly.
544
Pleural invasion of lung carcinoma
Gieson-stained slides in 1488 patients with surgically resected lung carcinoma. In the present study, we examined whether the outcome of patients with pl0 tumours was better than that of patients with pl1 tumours and whether such outcomes were influenced by other prognostic factors. In several previous reports, patients with tumours exhibiting pleural invasion had worse outcomes than those with tumours without pleural invasion (3 -8) . Osaki et al. (6) and Shimizu et al. (7, 8) reported that pleural invasion was a prognostic indicator, and patients with pl1 or pl2 tumours had worse outcomes than those with pl0 tumours. Conversely, Sakakura et al. reported that the outcome differed between patients with pl0-1 tumours and those with pl2 tumours (13) . In the present study, we concluded that the patients with pl1 tumours had worse outcomes than those with pl0 tumours, whereas no significant difference in OS was detected among patients with pl1, pl2, and pl3 tumours. The presence of pleural invasion was a significant prognostic factor independently of tumour size, histology of tumour, lymph node status, age, gender, and smoking status. Clinical outcomes significantly differed between patients with pl0 tumours and those with pl1 tumours among patients with 1, 2 cm (P ¼ 0.004), 2 , 3 cm (P ¼ 0.003) and 3 , 5 cm (P ¼ 0.02) tumours. Our result suggested that tumours with pleural invasion might require upstaging, if the tumour size was 1 , 2 cm, 2 , 3 cm or 3 , 5 cm.
The clinical outcomes were significantly different between patients with pl0 tumours and those with pl1 tumours, particularly among patients with adenocarcinoma (P , 0.0001), but not among those with squamous cell carcinoma (P ¼ 0.043). The result might be associated with increased numbers of small-sized, minimally invasive pl0 adenocarcinomas with good prognosis, and a certain number of squamous cell carcinomas localized centrally without associating with the pleura. The clinical outcomes were significantly different between patients with pl0 tumours and those with pl1 tumours among patients without lymph node metastasis (P , 0.0001); however, no significant difference was detected among patients with lymph node metastasis. Our result suggested that pleural invasion influenced patient outcome, especially among patients with adenocarcinoma and those without lymph node metastasis.
The location of pl3 pleural invasion did not significantly affect outcome. It was possible that this result was due to the small number of pl3 cases. Patients with interlobar pl3 tumours tended to have better outcomes than those with mediastinal or lateral pl3 tumours, and patients with mediastinal or lateral pl3 tumours tended to have better outcomes than those with diaphragmatic pl3 tumours. From our results, it was reasonable to classify mediastinal pl3 tumours as pT3.
In conclusion, clinical outcome differed between patients with pl0 tumours and those with pl1 -3 tumours, particularly among patients with 1 , 2 cm, 2 , 3 cm and 3 , 5 cm tumours, those with adenocarcinoma histology and those without lymph node metastasis. The location of pl3 pleural invasion did not affect outcome significantly. OS curves compared by the location of pl3 tumours in 135 patients. The outcomes for the 20 patients with interlobar pl3 tumours tended to be better and those for the 15 patients with diaphragmatic pl3 tumours tended to be worse than the outcomes for other patient groups, but significant differences were not detected among the 4 groups.
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